Old Web
English
Sign In
Acemap
>
authorDetail
>
Sepand Razavi-vakhshourpour
Sepand Razavi-vakhshourpour
Pasteur Institute of Iran
Antibody
Biology
Antibody-drug conjugate
Immunology
Chemistry
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development of a new anti‐CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker
2018
Biotechnology and Applied Biochemistry
Meghdad Abdollahpour Alitappeh
Sepand Razavi-vakhshourpour
Mohsen Abolhassani
Show All
Source
Cite
Save
Citations (4)
Monomethyl auristatin E Exhibits Potent Cytotoxic Activity against Human Cancer Cell Lines SKBR3 and HEK293
2017
Novelty in Biomedicine
Meghdad Abdollahpour Alitappeh
Sepand Razavi-vakhshourpour
Majid Lotfinia
Saeed Jahandideh
Hamid Najminejad
Saeed Balalaie
Reza Moazzami
Elnaz Shams
Mahdi Habibi Anbouhi
Mohsen Abolhassani
Show All
Source
Cite
Save
Citations (2)
Monomethyl Auristatin E, a Potent Cytotoxic Payload for Development of Antibody-Drug Conjugates against Breast Cancer
2017
Novelty in Biomedicine
Meghdad Abdollahpour Alitappeh
Amir Amanzadeh
Fatemeh Heidarnejad
Mahdi Habibi Anbouhi
Majid Lotfinia
Sepand Razavi-vakhshourpour
Saeed Jahandideh
Hamid Najminejad
Saeed Balalaie
Mohsen Abolhassani
Show All
Source
Cite
Save
Citations (2)
Evaluation of Factors Influencing Antibody Reduction for Development of Antibody Drug Conjugates
2017
Iranian biomedical journal
Meghdad Abdollahpour Alitappeh
Majid Lotfinia
Sepand Razavi-vakhshourpour
Saeed Jahandideh
Hamid Najminejad
Koushan Sineh Sepehr
Reza Moazami
Elnaz Shams
Mahdi Habibi Anbouhi
Mohsen Abolhassani
Show All
Source
Cite
Save
Citations (7)
1